Expansion Opportunity CIVCO is investing in a new 96,000 square-foot facility with a $15M budget and plans to centralize departments, signaling anticipated growth and increased demand for ultrasound infection control, high-level disinfection, and needle guidance devices. This presents chances to offer scalable infection control solutions, ongoing service contracts, and expanded hardware and consumables as capacity expands.

Geographic Growth The Iowa City/Coralville expansion indicates a strategic regional footprint strengthening. Engage with the new facility and SouthGate partnerships to introduce training programs, localized maintenance, and regionally tailored supply chains for faster delivery of probes, covers, and guidance technology.

Ultrasound Focus CIVCO specializes in ultrasound infection control, high-level disinfection, and transperineal prostate solutions. There is a clear opportunity to upsell advanced disinfection protocols, single-use or easily disposable probe covers, and EM needle tracking systems to radiology and urology departments expanding their ultrasound capabilities.

Compliance & Tech With ISO 9001 certification and a tech stack including Salesforce and iCIMS, CIVCO prioritizes quality and scalable operations. Propose value-added services such as compliance audits, streamlined procurement integrations, and analytics-ready purchasing to improve procurement efficiency for hospital networks.

Revenue Synergies A mid-market revenue range and ambitious growth efforts suggest opportunities in bundled offerings combining infection control, needle guidance, and device accessories. Target larger hospital and health system accounts with cross-sell of new facility launches, training, and service agreements to drive higher ticket sales.